These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19833831)

  • 1. COLD-PCR finds hot application in mutation analysis.
    Luthra R; Zuo Z
    Clin Chem; 2009 Dec; 55(12):2077-8. PubMed ID: 19833831
    [No Abstract]   [Full Text] [Related]  

  • 2. Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma.
    Li J; Milbury CA; Li C; Makrigiorgos GM
    Hum Mutat; 2009 Nov; 30(11):1583-90. PubMed ID: 19760750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations.
    Milbury CA; Li J; Makrigiorgos GM
    Clin Chem; 2009 Dec; 55(12):2130-43. PubMed ID: 19815609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMSO Increases Mutation Scanning Detection Sensitivity of High-Resolution Melting in Clinical Samples.
    Song C; Castellanos-Rizaldos E; Bejar R; Ebert BL; Makrigiorgos GM
    Clin Chem; 2015 Nov; 61(11):1354-62. PubMed ID: 26432802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COLD-PCR: improving the sensitivity of molecular diagnostics assays.
    Milbury CA; Li J; Liu P; Makrigiorgos GM
    Expert Rev Mol Diagn; 2011 Mar; 11(2):159-69. PubMed ID: 21405967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases.
    Wu J; Zhou Y; Zhang CY; Song BB; Wang BL; Pan BS; Lou WH; Guo W
    Asian Pac J Cancer Prev; 2014; 15(24):10647-52. PubMed ID: 25605154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced ratio of signals enables digital mutation scanning for rare allele detection.
    Castellanos-Rizaldos E; Paweletz C; Song C; Oxnard GR; Mamon H; Jänne PA; Makrigiorgos GM
    J Mol Diagn; 2015 May; 17(3):284-92. PubMed ID: 25772705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the P53 tumour suppressor gene in primary lung cancer in Japan.
    Kondo K; Umemoto A; Akimoto S; Uyama T; Hayashi K; Ohnishi Y; Monden Y
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1139-46. PubMed ID: 1348931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis.
    Kristensen LS; Andersen GB; Hager H; Hansen LL
    Hum Mutat; 2012 Jan; 33(1):264-71. PubMed ID: 21901793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of immunohistochemistry-laser microdissection-PCR technique in detecting p53 gene mutation in paraffin sections of gastric cancer].
    Xu JH; Chen LR; Wang HJ; Yao LF
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):342-5. PubMed ID: 15363320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining COLD-PCR and high-resolution melt analysis for rapid detection of low-level, rifampin-resistant mutations in Mycobacterium tuberculosis.
    Pang Y; Liu G; Wang Y; Zheng S; Zhao YL
    J Microbiol Methods; 2013 Apr; 93(1):32-6. PubMed ID: 23396215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.
    Li ZH; Zheng J; Weiss LM; Shibata D
    Am J Pathol; 1994 Feb; 144(2):303-9. PubMed ID: 8311114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COLD-PCR: Applications and Advantages.
    Zuo Z; Jabbar KJ
    Methods Mol Biol; 2016; 1392():17-25. PubMed ID: 26843042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
    Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison Between Full-COLD PCR/HRM and PCR Sequencing for Detection of Mutations in Exon 9 of PIK3CA in Breast Cancer Patients.
    Ghalamkari S; Khosravian F; Mianesaz H; Kazemi M; Behjati M; Hakimian SM; Salehi M
    Appl Biochem Biotechnol; 2019 Mar; 187(3):975-983. PubMed ID: 30109561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.
    Cortot AB; Younes M; Martel-Planche G; Guibert B; Isaac S; Souquet PJ; Commo F; Girard P; Fouret P; Brambilla E; Hainaut P; Soria JC
    Clin Lung Cancer; 2014 Mar; 15(2):124-30. PubMed ID: 24169260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.